Company Trimurthi Limited

Equities

TRIMURTHI6

INE314I01036

Investment Banking & Brokerage Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sector Other Investment Banking & Brokerage Services

Delayed Bombay S.E. Other stock markets 03:30:55 24/06/2024 pm IST			5-day change	1st Jan Change
18.94 ^INR	0.00%		0.00%	+68.36%

11/06	Trimurthi Limited announced that it has received INR 19 million in funding	CI
28/05	Trimurthi Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Trimurthi Limited is an India-based company, which is engaged in the business of trading of pharmaceuticals and related products and is into the business of trading of shares and securities. The Company's segments include Pharma Business, Financial Services, Investments, Trading in Shares and Foods. Its services include distribution network for pharmaceutical products, retail pharmacy and marketing. Its products include T-SIF-O, Polyflic XT, Ulcizole-DSR, Auscomin-S, T-SIF 200, ACLO-P, LAMITAB, Oriflox, Treb-DSR, Conplus and Volivia Gold.

Number of employees: 7

INR in Million	2022	Weight	2023	Weight	Delta
Trading in Shares 62.0 %	8	8.3 %	12	62.0 %	+57.55%
Financial 14.2 %	3	3.3 %	3	14.2 %	-8.43%
Investment 12.7 %	3	2.8 %	2	12.7 %	-4.29%
Pharma 11.1 %	79	85.7 %	2	11.1 %	-97.29%

INR in Million	2022	Weight	2023	Weight	Delta
India 100.0 %	92	100.0 %	19	100.0 %	-79.04%

Managers	Title	Age	Since
Ravi Bhangadia CEO	Chief Executive Officer	-	09/23/09
Vani Manda DFI	Director of Finance/CFO	-	04/14/04
Nishita Kalantri CMP	Compliance Officer	-	01/19/01
Arvind Kumar Bhangadia BRD	Director/Board Member	50	04/05/04
Sanskriti SAM	Sales & Marketing	-	01/21/01

Members of the board	Title	Age	Since
Arvind Kumar Bhangadia BRD	Director/Board Member	50	04/05/04
Natwarlal Ramgopal Modani BRD	Director/Board Member	43	13/17/13
Sagar Rajendra Karwa BRD	Director/Board Member	34	07/16/07
Monam Kapoor BRD	Director/Board Member	35	07/22/07
Ravi Bhangadia CEO	Chief Executive Officer	-	09/23/09
Aditya Bhangadia CHM	Chairman	-	09/23/09

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	10,000,000	1,849,267 ( 18.49 %)	0	18.49 %

Trimurthi Ltd.

Ratna Block, Raghav Ratna Towers 5-8-354/1106, Office No. 1106

500001, Hyderabad

http://www.trimurthidrugs.com

Financials

Banking & Investment Services

Investment Banking & Investment Services

Investment Banking & Brokerage Services

Other Investment Banking & Brokerage Services

	1st Jan change	Capi.
TRIMURTHI LIMITED	+68.36%	2.27M
THE GOLDMAN SACHS GROUP, INC.	+18.56%	155B
CHARLES SCHWAB	+7.41%	135B
CITIGROUP INC.	+19.71%	117B
CITIC SECURITIES COMPANY LIMITED	-11.05%	34.4B
RAYMOND JAMES FINANCIAL, INC.	+9.14%	25.22B
LPL FINANCIAL HOLDINGS INC.	+21.25%	20.62B
CSC FINANCIAL CO., LTD.	-13.33%	18.6B
NOMURA HOLDINGS, INC.	+47.17%	17.28B
CHINA MERCHANTS SECURITIES CO., LTD.	+3.74%	15.48B

Other Investment Banking & Brokerage Services